Flexion Therapeutics Cash Flow - Quarterly (NASDAQ:FLXN)

Add to My Stocks
$18.43 $0.44 (2.33%) FLXN stock closing price Sep 21, 2018 (Closing)

For analyzing any company like Flexion Therapeutics from an investment perspective, its important to check the cash flow statement. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Flexion Therapeutics profits and Flexion Therapeutics debt. Flexion Therapeutics cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Flexion Therapeutics had cash and cash equivalents of $30.91M at the beginning of the quarter and $174.56M at quarter end for 2018 Q2. Flexion Therapeutics saw a inflow of $130.29M from investing activities till 2018 Q2.

View and download details of Flexion Therapeutics cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow4.41M2.21M7.16M4.79M2.37M-1.87M1.24M--
Net Increase (Decrease) in Assets Liabilities-8.63M-9.28M11.79M9.32M3.98M-0.24M-1M-0.94M-0.46M-1.49M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net7.63M3.65M10.68M6.89M4.16M2.12M8.54M6.99M5.53M3.92M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.56M-0.33M-2.14M-1.88M-1.68M-1.01M-8.43M-8.16M-7.67M-3.09M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments130.85M66.91M-116.52M3.82M17.04M34.87M-123.91M-39.25M11.18M13.09M
Other Cash Inflow (Outflow) from Investment Activities---0.12M-0.12M-0.12M-0.09M-0.4M---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares2.9M-137.54M3.53M1.91M-148.53M78.05M77.93M-
Issuance (Repayment) of Debt Securities-5M-2.5M192.91M195.41M197.91M-0.83M15M15M--
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---6.96M-6.56M-6.56M-0.09M-0.33M-0.29M-0.07M-0.04M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year30.91M62.94M103.09M16.18M12.83M3.35M4.8M4.8M--
Cash & Equivalents at Year End174.56M147.9M127.78M159.17M197.17M42.92M30.91M66.8M119.01M58.9M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Radius Health financial analysis

While Flexion Therapeutics stock price history provides the price history of a stock, Flexion Therapeutics stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Flexion Therapeutics had a Net Change in Cash and Cash Equivalents of $46.17M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Flexion Therapeutics stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Flexion Therapeutics lost $-82.02M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a positive value of $130.29M for FLXN stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Flexion Therapeutics spent $-2.09M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Flexion Therapeutics Cash Flow

Quarterly Cash Flow Statements For Flexion Therapeutics Inc Peers

Radius Health cash flow, Sucampo Pharma cash flow, Sagent Pharma cash flow